DE602007008759D1 - Pyrroloä1,2-aüimidazoldion zur behandlung von peripherer neurotoxizität durch chemotherapeutische mittel - Google Patents

Pyrroloä1,2-aüimidazoldion zur behandlung von peripherer neurotoxizität durch chemotherapeutische mittel

Info

Publication number
DE602007008759D1
DE602007008759D1 DE602007008759T DE602007008759T DE602007008759D1 DE 602007008759 D1 DE602007008759 D1 DE 602007008759D1 DE 602007008759 T DE602007008759 T DE 602007008759T DE 602007008759 T DE602007008759 T DE 602007008759T DE 602007008759 D1 DE602007008759 D1 DE 602007008759D1
Authority
DE
Germany
Prior art keywords
pyrroloa1
aimidazoldion
treatment
chemotherapeutic agents
peripheral neurotoxicity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007008759T
Other languages
English (en)
Inventor
Carlo Farina
Carla Ghelardini
Paola Petrillo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neurotune AG
Original Assignee
Neurotune AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37882430&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602007008759(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Neurotune AG filed Critical Neurotune AG
Publication of DE602007008759D1 publication Critical patent/DE602007008759D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE602007008759T 2006-11-15 2007-11-14 Pyrroloä1,2-aüimidazoldion zur behandlung von peripherer neurotoxizität durch chemotherapeutische mittel Active DE602007008759D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06124142A EP1925304A1 (de) 2006-11-15 2006-11-15 Pyrrolo[1,2-a]imidazoledione zur Behandlung von durch Chemotherapie ausgelöster peripherer Neuropathie
PCT/EP2007/062323 WO2008058988A1 (en) 2006-11-15 2007-11-14 Pyrrolo[1,2-a]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents

Publications (1)

Publication Number Publication Date
DE602007008759D1 true DE602007008759D1 (de) 2010-10-07

Family

ID=37882430

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007008759T Active DE602007008759D1 (de) 2006-11-15 2007-11-14 Pyrroloä1,2-aüimidazoldion zur behandlung von peripherer neurotoxizität durch chemotherapeutische mittel

Country Status (19)

Country Link
US (1) US7973066B2 (de)
EP (2) EP1925304A1 (de)
JP (1) JP2010509389A (de)
CN (1) CN101605541A (de)
AR (1) AR063819A1 (de)
AT (1) ATE478668T1 (de)
AU (1) AU2007321218A1 (de)
BR (1) BRPI0718904A2 (de)
CA (1) CA2669853A1 (de)
CL (1) CL2007003281A1 (de)
DE (1) DE602007008759D1 (de)
EA (1) EA200900552A1 (de)
ES (1) ES2347380T3 (de)
IL (1) IL198689A0 (de)
MX (1) MX2009005125A (de)
NZ (1) NZ576995A (de)
PE (1) PE20081494A1 (de)
WO (1) WO2008058988A1 (de)
ZA (1) ZA200904148B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20030573A1 (it) * 2003-03-24 2004-09-25 Nikem Research Srl Composti ad azione nootropica, loro preparazione,
US9125898B2 (en) 2008-11-14 2015-09-08 Neurotune Ag Acetam derivatives for pain relief
RU2017106172A (ru) * 2014-07-31 2018-08-28 Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед Применение антагонистов cxcr2 для предотвращения и/или лечения периферической невропатии, вызванной химиотерапией (cipn)
WO2021043673A1 (en) * 2019-09-02 2021-03-11 Syddansk Universitet P-gp inducers as protectors against chemotherapy-induced side effects, such as peripheral neuropathy (cipn) and hair loss

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20030573A1 (it) * 2003-03-24 2004-09-25 Nikem Research Srl Composti ad azione nootropica, loro preparazione,

Also Published As

Publication number Publication date
IL198689A0 (en) 2010-02-17
ZA200904148B (en) 2010-04-28
CA2669853A1 (en) 2008-05-22
CL2007003281A1 (es) 2008-06-27
PE20081494A1 (es) 2008-12-19
AR063819A1 (es) 2009-02-18
MX2009005125A (es) 2009-11-02
NZ576995A (en) 2010-12-24
EP1925304A1 (de) 2008-05-28
AU2007321218A1 (en) 2008-05-22
JP2010509389A (ja) 2010-03-25
US7973066B2 (en) 2011-07-05
WO2008058988A1 (en) 2008-05-22
ES2347380T3 (es) 2010-10-28
EP2094265B1 (de) 2010-08-25
ATE478668T1 (de) 2010-09-15
CN101605541A (zh) 2009-12-16
US20100062077A1 (en) 2010-03-11
EP2094265A1 (de) 2009-09-02
BRPI0718904A2 (pt) 2013-12-10
EA200900552A1 (ru) 2009-10-30

Similar Documents

Publication Publication Date Title
ATE429218T1 (de) Pinolensäure zur behandlung von übergewicht
ATE521365T1 (de) Kinin-antagonisten zur behandlung von blasenfunktionsstörung
ATE434620T1 (de) Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
ATE550329T1 (de) Heterobicyclische sulfonamidderivate zur behandlung von diabetes
DE602006020327D1 (de) 2-phenoxy-n-(1,3,4-thiadizol-2-yl)pyridin-3-aminder-hemmer zur behandlung thromboembolischer erkrankungen
ATE527241T1 (de) Pyridiazinonderivate zur behandlung von tumoren
DE602005015234D1 (de) Zusammensetzungen zur wäschebehandlung
DE602005014252D1 (de) Zusammensetzungen zur wäschebehandlung
DE602006019560D1 (de) 2-cyanobenzolsulfonamidverbindungen zur behandlung von samen
DE602005026984D1 (de) Chinolin-derivate zur behandlung von latenter tuberkulose
ATE554091T1 (de) Aminotetrahydropyrane als dipeptidylpeptidase-iv- inhibitoren zur behandlung oder prävention von diabetes
DE602005017503D1 (de) Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen
ATE493986T1 (de) Diarylharnstoffe zur behandlung von pulmonaler hypertonie
LTC2805723I2 (lt) Kladribino režimas, skirtas išsėtinei sklerozei gydyti
ATE532507T1 (de) Neramexane zur behandlung von subakuten tinnitus
DE602006010449D1 (de) Behandlung von geflügel zwecks reduzierung der futon ascites
DE502006008804D1 (de) Neue, langwirksame betamimetika zur behandlung von atemwegserkrankungen
DE602006003094D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit
DE602006005640D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate als arzneimittel zur behandlung von unfruchtbarkeit
DE602005016141D1 (de) S-mirtazapin zur behandlung von hitzewallungen
DE602006021192D1 (de) Visnadin zur Behandlung von Kopfhautjucken
ATE526970T1 (de) Behandlung von mastitis
DE602006006950D1 (de) Zusammensetzungen, Verwendungen und Kit für die Behandlung von Dermatitis
DE602006002608D1 (de) 4-phenyl-5-oxo-l,4,5,6,7,8-hexahydrochinolin-derivate als arzneimittel zur behandlung von unfruchtbarkeit
ATE532787T1 (de) Polycyclische mittel zur behandlung von infektionen mit dem respiratory syncytial virus